Perrigo (PRGO)

• Market cap: $3.51B
• 1 day: 0.39%
• 5 days: 3.46%
• 1 month: -8.27%
• 3 months: 3.17%
• 6 months: 1.14%
• Year to date: -1.08%
• 1 year: -21.25%
• 5 years: -51.74%
• 10 years: -85.97%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

Employees: 8,379

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

489% more call options, than puts

Call options by funds: $63.2M | Put options by funds: $10.7M

23% more first-time investments, than exits

New positions opened: 58 | Existing positions closed: 47

22% more funds holding in top 10

Funds holding in top 10: 9 [Q3] → 11 (+2) [Q4]

2.42% more ownership

Funds ownership: 95.78% [Q3] → 98.2% (+2.42%) [Q4]

2% more funds holding

Funds holding: 345 [Q3] → 353 (+8) [Q4]

1% more capital invested

Capital invested by funds: $3.43B [Q3] → $3.45B (+$18.2M) [Q4]

13% less repeat investments, than reductions

Existing positions increased: 118 | Existing positions reduced: 136